CPC C07K 14/515 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0021 (2013.01); A61K 31/712 (2013.01); A61K 38/1866 (2013.01); A61K 47/12 (2013.01); A61P 9/10 (2018.01); A61P 17/02 (2018.01)] | 26 Claims |
1. A composition comprising a modified mRNA encoding a VEGF-A polypeptide of SEQ ID NO: 2 and a citrate saline buffer, wherein the citrate saline buffer is substantially free of divalent cations.
|